Table 2 Description of gravid, ABO blood group and malaria complications among the study groups
From: IFN-gamma and TNF associated with severe falciparum malaria infection in Saudi pregnant women
Dependant variables | MFC | UM | SM | P value |
|---|---|---|---|---|
n = 60 (32.3%) | n = 62 (33.3%) | n = 64 (34.4%) | ||
Gravidae | <0.001 | |||
Primigravidae | 4 (6.7%) | 54 (87.1%) | 56 (87.5%) | |
n = 114 (61.3%) | ||||
Multigravidae | 56 (93.3%) | 8 (12.9%) | 8 (12.5%) | |
n = 72 (38.7%) | ||||
ABO | <0.001 | |||
O n = 124 (66.7%) | 44 (73.3%) | 37 (59.7%) | 43 (67.2%) | |
A n = 20 (10.8%) | 8 (13.3%) | 4 (6.5%) | 8 (12.5%) | |
B n = 30 (16.1%) | 4 (6.7%) | 18 (29%) | 8 (12.5%) | |
AB n = 12 (6.5%) | 4 (6.7%) | 3 (4.8%) | 5 (7.8%) | |
Malaria complications | <0.001 | |||
No complications | 60 (100%) | 62 (100%) | 0 (0%) | |
Anaemia | 0 (0%) | 0 (0%) | 49 (76.6%) | |
Cerebral malaria | 0 (0%) | 0 (0%) | 8 (12.5%) | |
Hypoglycaemia | 0 (0%) | 0 (0%) | 7 (10.9%) | |
Treatment | <0.001 | |||
No treatment | 60 (100%) | 0 (0%) | 0 (0%) | |
Quinine | 0 (0%) | 43 (69.4%) | 0 (0%) | |
ACT* | 0 (0%) | 19 (30.6%) | 0 (0%) | |
Artesunate plus quinine | 0 (0%) | 0 (0%) | 64 (100%) |